Medicated Personal Care Products Global Market Report 2025

The medicated personal care products market size has grown strongly in recent years. It will grow from $8.56 billion in 2024 to $9.01 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth during the historic period can be attributed to an increase in dermatological conditions, a growing geriatric population, the expansion of pharmaceutical retail chains, a surge in cosmetic dermatology procedures, and heightened awareness of health and wellness.

The medicated personal care products market size is expected to see steady growth in the next few years. It will grow to $10.91 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The projected growth in the forecast period can be attributed to increasing consumer awareness of skin health, a rising prevalence of skin conditions, growing demand for men’s grooming products, a surge in personalized skincare preferences, and a higher incidence of skin disorders. Key trends expected during this period include an emphasis on microbiome-friendly formulations, the use of artificial intelligence (AI) for personalized product recommendations, the emergence of hybrid products that combine cosmetic and therapeutic benefits, a shift toward clean labels and ingredient transparency, and the adoption of eco-friendly packaging solutions.

The increasing prevalence of skin disorders is expected to drive the growth of the medicated personal care products market in the coming years. Skin disorders are conditions that impact the appearance, structure, or function of the skin, including issues such as acne, eczema, and psoriasis. This rise in skin disorders is largely attributed to increased exposure to environmental pollutants, which can penetrate the skin barrier and lead to irritation, inflammation, and chronic conditions. Medicated personal care products are formulated with active ingredients that target these affected areas, helping to reduce inflammation, irritation, or infection while supporting the healing process and improving overall skin health. For example, in July 2024, Cancer Research UK, a UK-based cancer research organization, reported that the average annual number of new melanoma skin cancer cases in the UK is projected to grow from approximately 20,800 in 2023-2025 to around 26,500 in 2038-2040. This rising trend in skin disorders is contributing to the expansion of the medicated personal care products market.

Leading companies in the medicated personal care products market are focusing on developing advanced solutions such as antibacterial liquid soaps to enhance germ protection and deliver a more effective yet gentle cleansing experience for consumers. Antibacterial liquid soap is a medicated formulation that includes chemical agents specifically designed to kill or inhibit bacterial growth on the skin, thereby reducing infection risk and promoting hygiene. For example, in April 2023, Dettol, a UK-based hygiene brand, launched a reformulated version of its original liquid hand wash. The new formula provides 99.99% germ protection along with a moisture seal benefit. It features improved ingredients and has been dermatologically tested to ensure it is gentle on the skin, leaving hands feeling soft and nourished after each wash. This reformulation aims to offer a more efficient and skin-friendly hand hygiene solution.

In December 2023, Wipro Consumer Care and Lighting, an India-based personal care products company, acquired the brands Jo, Doy, and Bacter Shield from VVF Limited for an undisclosed amount. This strategic acquisition is intended to expand and diversify Wipro’s personal wash portfolio by incorporating these well-established brands, thereby enhancing its market presence and driving growth in key regional markets. VVF Limited is an India-based manufacturer of medicated personal care products.

Major players in the medicated personal care products market are Procter & Gamble (P&G), Johnson & Johnson Services Inc., Unilever PLC, Dow Inc., L'Oréal S.A, Henkel AG & Co. KGaA, Colgate-Palmolive Company, Kenvue Inc., Reckitt Benckiser Group plc, Haleon plc, Kao Corporation, Church & Dwight Co. Inc., Perrigo Company plc, Merz Pharma GmbH & Co.KGaA, Topix Pharmaceuticals Inc., Kutol Products Company Inc., Cosmetic Solutions, ARG Laboratories Inc., KPH Cosmos Pvt. Ltd., Eden Kingdom Essential.

North America was the largest region in the medicated personal care products market in 2024. The regions covered in medicated personal care products report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medicated personal care products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medicated personal care products are specialized formulations that combine therapeutic and cosmetic properties to treat or prevent specific conditions affecting the skin, scalp, or body. These products typically include active pharmaceutical ingredients that address medical concerns or infections while also promoting hygiene and personal grooming.

The primary categories of medicated personal care products include oral care, deodorants, feminine care, antiperspirants, body powders, hand sanitizers, and others. Oral care items are designed to support oral hygiene by preventing issues such as cavities, gum disease, and bad breath through active components like fluoride and antiseptics. These products are available in various beauty care formats, including shampoos, oils, soaps, moisturizers, gels, and more. They are distributed through multiple channels such as hypermarkets and supermarkets, specialty stores, e-commerce platforms, and others.

The medicated personal care products market research report is one of a series of new reports that provides medicated personal care products market statistics, including the medicated personal care products industry global market size, regional shares, competitors with the medicated personal care products market share, detailed medicated personal care products market segments, market trends, opportunities, and any further data you may need to thrive in the medicated personal care products industry. This medicated personal care products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medicated personal care products market consists of sales of anti-acne creams, antifungal powders, antiseptic lotions, and skin ointments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.